ARCHIVES

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Cancer Epidemiology Hampered By Bureaucratic Delays, Lack of Cooperation, NCI Group Says

September 29, 1978

Editorial: Ambiance Through Exclusion

May 20, 1994

Biggest NCI Budget Brings Large Headache: More Commitments, Rising Costs, Opportunities

December 8, 1989

Cancer Survivorship: NCI, Komen, OWH Fund Research Grants

December 5, 1997

High-Dose Chemo Doesn’t Improve Survival In Small Cell Lung Cancer

April 25, 2008

Unorthodox Panel Considers NIH Mandated Role In Study of Unconventional Medical Practices

June 26, 1992